Marie-Claude Morice

Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2

Garot P, Neylon A, Morice M, Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Schramm R, Cockburn J, Cunnington M, Wolf A, Barbanti M, Tchétché D, Pagnotta P, Gilard M, Bedogni F, Van Belle E, Vasa-Nicotera M, Chieffo A, Bogaerts K, Hengstenberg C, Capodanno D

April 22, 2022 | 10.4244/EIJ-D-21-01048

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hara H, Kawashima H, Ono M, Takahashi K, Mack M, Holmes D, Morice M, Davierwala P, Mohr F, Thuijs D, Kappetein AP, O'Leary N, van Klaveren D, Onuma Y, Serruys P

April 22, 2022 | 10.4244/EIJ-D-21-00415

Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown WM, Serruys P, Kappetein AP, Sabik J, Stone G

January 28, 2022 | 10.4244/EIJ-D-21-00338

Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients

Marquis-Gravel G, Urban P, Copt S, Capodanno D, Pocock S, Sadozai Slama S, Stoll H, Tanguay J, Mehran R, Leon M, Rao S, Morice M, Krucoff M

June 25, 2021 | 10.4244/EIJ-D-20-00749

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein AP, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein AP, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein AP, Sabik J, Dressler O, Mehran R, Sharma S, Stone G

June 25, 2020 | 10.4244/EIJ-D-19-00851

Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One

Buchanan G, Ortega R, Chieffo A, Mehran R, Gilard M, Morice M

May 20, 2020 | 10.4244/EIJV16I1A5

Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning AP, Morice M, Taggart D, Sabik J, Serruys P, Kappetein AP, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00263

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee

Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio A, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne R, Capretti G, Appelman Y, Morice M, Presbitero P, Radu M, Mauri Ferre J

December 7, 2018 | 10.4244/EIJ-D-18-00225

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning AP, Merkely B, Kappetein AP, Sabik J, Serruys P, Stone G

November 20, 2018 | 10.4244/EIJ-D-18-00711

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson TW, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein AP

May 20, 2018 | 10.4244/EIJ-D-17-00620

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong P, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M

February 20, 2018 | 10.4244/EIJ-D-17-00286

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein AP, Mohr F, Colombo A, Feldman T, Morice M

September 20, 2017 | 10.4244/EIJ-D-16-00991

Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes

Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y

February 3, 2017 | 10.4244/EIJ-D-15-00278

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

Varenne O, Cuisset T, Chaib A, Morice M, Sabaté M, Koh T-H, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P

January 20, 2017 | 10.4244/EIJY15M12_02

Marie-Claude Morice

Latest news